106 related articles for article (PubMed ID: 8894802)
1. Inhibition of interleukin-1 type I receptor expression in human cell-lines by an antisense phosphorothioate oligodeoxynucleotide.
Miraglia L; Geiger T; Bennett CF; Dean NM
Int J Immunopharmacol; 1996 Apr; 18(4):227-40. PubMed ID: 8894802
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.
Dean NM; McKay R; Condon TP; Bennett CF
J Biol Chem; 1994 Jun; 269(23):16416-24. PubMed ID: 7911467
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
Dean N; McKay R; Miraglia L; Howard R; Cooper S; Giddings J; Nicklin P; Meister L; Ziel R; Geiger T; Muller M; Fabbro D
Cancer Res; 1996 Aug; 56(15):3499-507. PubMed ID: 8758918
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.
Chiang MY; Chan H; Zounes MA; Freier SM; Lima WF; Bennett CF
J Biol Chem; 1991 Sep; 266(27):18162-71. PubMed ID: 1680858
[TBL] [Abstract][Full Text] [Related]
5. Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.
Saijo Y; Uchiyama B; Abe T; Satoh K; Nukiwa T
Jpn J Cancer Res; 1997 Jan; 88(1):26-33. PubMed ID: 9045892
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.
Burch RM; Mahan LC
J Clin Invest; 1991 Oct; 88(4):1190-6. PubMed ID: 1833422
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.
Bennett CF; Condon TP; Grimm S; Chan H; Chiang MY
J Immunol; 1994 Apr; 152(7):3530-40. PubMed ID: 7511650
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.
Dean NM; McKay R
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11762-6. PubMed ID: 7972137
[TBL] [Abstract][Full Text] [Related]
9. Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes.
Nestle FO; Mitra RS; Bennett CF; Chan H; Nickoloff BJ
J Invest Dermatol; 1994 Oct; 103(4):569-75. PubMed ID: 7930684
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of interleukin-10 production in murine macrophage-like cells by phosphorothioate antisense oligonucleotides.
Arima H; Takahashi M; Aramaki Y; Sakamoto T; Tsuchiya S
Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):319-27. PubMed ID: 9743469
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of interferon-gamma-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consequence of antisense-specific and antisense-non-specific effects.
Hertl M; Neckers LM; Katz SI
J Invest Dermatol; 1995 May; 104(5):813-8. PubMed ID: 7738361
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 down-regulates type I interleukin 1 receptor mRNA expression in a human fibroblast cell line TIG-1 in the absence of prostaglandin E2 synthesis.
Takii T; Hayashi H; Marunouchi T; Onozaki K
Lymphokine Cytokine Res; 1994 Jun; 13(3):213-9. PubMed ID: 7948430
[TBL] [Abstract][Full Text] [Related]
13. Design of potent phosphorothioate antisense oligonucleotides directed to human interleukin 10 gene product and their evaluation of antisense activity in U937 cells.
Arima H; Takahashi M; Aramaki Y; Sakamoto T; Yuda K; Akiyama K; Goto T; Tsuchiya S
Pharm Res; 1999 Aug; 16(8):1163-71. PubMed ID: 10468015
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of methylcholanthrene-induced neoplastic transformation in murine C3H 10T1/2 fibroblasts by antisense phosphorothioate oligodeoxynucleotide sequences.
Lesoon-Wood LA; Pierce LM; Lau AF; Cooney RV
Cancer Lett; 1999 Dec; 147(1-2):163-73. PubMed ID: 10660102
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.
Monia BP; Johnston JF; Geiger T; Muller M; Fabbro D
Nat Med; 1996 Jun; 2(6):668-75. PubMed ID: 8640558
[TBL] [Abstract][Full Text] [Related]
16. Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells.
Müller M; Dietel M; Turzynski A; Wiechen K
Int J Cancer; 1998 Aug; 77(4):567-71. PubMed ID: 9679760
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev.
Lund OS; Nielsen JO; Hansen JE
Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762
[TBL] [Abstract][Full Text] [Related]
19. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.
Yokozaki H; Budillon A; Tortora G; Meissner S; Beaucage SL; Miki K; Cho-Chung YS
Cancer Res; 1993 Feb; 53(4):868-72. PubMed ID: 8428367
[TBL] [Abstract][Full Text] [Related]
20. Cellular pharmacology of p120 antisense oligodeoxynucleotide phosphorothioate ISIS 3466.
Saijo Y; Perlaky L; Valdez BC; Wang H; Henning D; Busch H
Oncol Res; 1993; 5(8):283-91. PubMed ID: 8012060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
